BG107266A - Кристална форма на терапевтично средство - Google Patents

Кристална форма на терапевтично средство Download PDF

Info

Publication number
BG107266A
BG107266A BG107266A BG10726602A BG107266A BG 107266 A BG107266 A BG 107266A BG 107266 A BG107266 A BG 107266A BG 10726602 A BG10726602 A BG 10726602A BG 107266 A BG107266 A BG 107266A
Authority
BG
Bulgaria
Prior art keywords
ethyl
compound
ethoxy
mol
mixture
Prior art date
Application number
BG107266A
Other languages
Bulgarian (bg)
English (en)
Inventor
Laurence HARRIS
Richard Storey
Albert Wood
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018656A external-priority patent/GB0018656D0/en
Priority claimed from GB0106464A external-priority patent/GB0106464D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG107266A publication Critical patent/BG107266A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BG107266A 2000-07-28 2002-11-12 Кристална форма на терапевтично средство BG107266A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent
PCT/IB2001/001280 WO2002010171A1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent

Publications (1)

Publication Number Publication Date
BG107266A true BG107266A (bg) 2003-07-31

Family

ID=26244756

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107266A BG107266A (bg) 2000-07-28 2002-11-12 Кристална форма на терапевтично средство

Country Status (46)

Country Link
EP (1) EP1305314B1 (xx)
JP (1) JP2004505087A (xx)
KR (1) KR100457937B1 (xx)
CN (1) CN1207297C (xx)
AP (1) AP1400A (xx)
AR (1) AR032628A1 (xx)
AT (1) ATE286901T1 (xx)
AU (2) AU2001272690B2 (xx)
BG (1) BG107266A (xx)
BR (1) BR0112734A (xx)
CA (1) CA2417264C (xx)
CZ (1) CZ2003126A3 (xx)
DE (1) DE60108398T2 (xx)
DO (1) DOP2001000217A (xx)
DZ (1) DZ3364A1 (xx)
EA (1) EA004681B1 (xx)
EC (1) ECSP034454A (xx)
EE (1) EE200300045A (xx)
ES (1) ES2231521T3 (xx)
GE (1) GEP20053494B (xx)
HK (1) HK1055954A1 (xx)
HR (1) HRP20030061A2 (xx)
HU (1) HUP0302982A3 (xx)
IL (1) IL153226A0 (xx)
IN (1) IN2002MU01649A (xx)
IS (1) IS6626A (xx)
MA (1) MA26931A1 (xx)
MX (1) MX233602B (xx)
MY (1) MY117831A (xx)
NO (1) NO324220B1 (xx)
NZ (1) NZ523226A (xx)
OA (1) OA12337A (xx)
PA (1) PA8523501A1 (xx)
PE (1) PE20020277A1 (xx)
PH (1) PH12001001922B1 (xx)
PL (1) PL365133A1 (xx)
PT (1) PT1305314E (xx)
SK (1) SK572003A3 (xx)
SV (1) SV2001000570A (xx)
TN (1) TNSN01112A1 (xx)
TW (1) TWI285643B (xx)
UA (1) UA72631C2 (xx)
UY (1) UY26854A1 (xx)
WO (1) WO2002010171A1 (xx)
YU (1) YU4703A (xx)
ZA (1) ZA200301457B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
JP4015176B2 (ja) 2003-04-29 2007-11-28 ファイザー・インク 高血圧症の治療に有用な５，７−ジアミノピラゾロ４，３−ジピリミジン類
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
BRPI0509731A (pt) 2004-04-07 2007-09-25 Pfizer pirazol[4,3-d]pirimidinas
PT1881985E (pt) 2005-05-12 2011-02-01 Pfizer Formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n- -etil-n-metilamino)-7-(4-metilpiridin-2-il-amino)-1h- -pirazolo[4,3-d]pirimidino-3-carbonil]metanossulfonamida

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1073658B1 (en) * 1998-04-20 2003-08-13 Pfizer Inc. Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

Also Published As

Publication number Publication date
ES2231521T3 (es) 2005-05-16
GEP20053494B (en) 2005-04-25
EP1305314B1 (en) 2005-01-12
AU2001272690B2 (en) 2005-12-08
SV2001000570A (es) 2002-09-03
ATE286901T1 (de) 2005-01-15
TWI285643B (en) 2007-08-21
AR032628A1 (es) 2003-11-19
AU7269001A (en) 2002-02-13
EA200300079A1 (ru) 2003-06-26
UY26854A1 (es) 2002-02-28
YU4703A (sh) 2006-01-16
HUP0302982A3 (en) 2005-01-28
TNSN01112A1 (fr) 2005-11-10
NO324220B1 (no) 2007-09-10
MA26931A1 (fr) 2004-12-20
IN2002MU01649A (xx) 2004-12-11
HUP0302982A2 (hu) 2003-12-29
DZ3364A1 (fr) 2002-02-07
EE200300045A (et) 2004-12-15
IS6626A (is) 2002-11-18
WO2002010171A1 (en) 2002-02-07
AP1400A (en) 2005-04-28
PH12001001922B1 (en) 2006-11-21
MXPA03000856A (es) 2003-06-06
CZ2003126A3 (cs) 2004-02-18
KR20030016430A (ko) 2003-02-26
SK572003A3 (en) 2004-05-04
ZA200301457B (en) 2004-04-28
NO20030416L (no) 2003-02-05
CN1444585A (zh) 2003-09-24
PL365133A1 (en) 2004-12-27
EA004681B1 (ru) 2004-06-24
KR100457937B1 (ko) 2004-11-20
CA2417264C (en) 2007-06-12
UA72631C2 (uk) 2005-03-15
CA2417264A1 (en) 2002-02-07
MY117831A (en) 2004-08-30
PA8523501A1 (es) 2002-10-24
BR0112734A (pt) 2004-08-10
NO20030416D0 (no) 2003-01-27
EP1305314A1 (en) 2003-05-02
MX233602B (es) 2006-01-10
HK1055954A1 (en) 2004-01-30
PE20020277A1 (es) 2002-05-11
DE60108398D1 (de) 2005-02-17
JP2004505087A (ja) 2004-02-19
DOP2001000217A (es) 2002-10-30
PT1305314E (pt) 2005-04-29
CN1207297C (zh) 2005-06-22
IL153226A0 (en) 2003-07-06
HRP20030061A2 (en) 2003-04-30
OA12337A (en) 2006-05-15
DE60108398T2 (de) 2005-12-22
ECSP034454A (es) 2003-03-10
AP2001002234A0 (en) 2001-09-30
NZ523226A (en) 2003-07-25

Similar Documents

Publication Publication Date Title
KR100549152B1 (ko) 피라졸로[4,3-ｄ]피리미딘 유도체
MXPA06000484A (es) Sal de isetionato de un inhibidor selectivo de la quinasa 4 dependiente de ciclina.
US9902698B2 (en) 2-[[[2-[(Hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
ES2331487T3 (es) Forma cristalina estable de bifeprunox mesilato, formas de dosificacion del mismo y metodos de utilizacion.
BG107266A (bg) Кристална форма на терапевтично средство
US6420557B1 (en) Crystalline therapeutic agent
US6350751B1 (en) Therapeutic agents
AU2001272690A1 (en) Crystalline therapeutic agent
ES2219395T3 (es) Sal anhidra.
RU2802964C2 (ru) Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида